Elsevier

Radiotherapy and Oncology

Volume 104, Issue 3, September 2012, Pages 317-323
Radiotherapy and Oncology

RT of nasopharyngeal carcinoma
A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients

https://doi.org/10.1016/j.radonc.2012.03.013Get rights and content

Abstract

Background and purpose

Significant tumor shrinkage and weight loss may occur during Intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC). This study aims to evaluate the dosimetric effect of volumetric changes on target volumes and organs at risk (OARs) during IMRT, using reassessment of computed tomography (CT) and magnetic resonance imaging (MRI).

Material and methods

Nineteen loco-regionally advanced NPC patients treated with IMRT were recruited prospectively. Repeat planning CT and MRI were acquired at 30 and 50 Gy intervals. Recontouring of target volumes and OARs was based on the fused CT-MRI images. Hybrid plans with recontouring were generated. The assessment of volumetric and dosimetric changes was performed by comparing the hybrid plans with the original plan.

Results

There was volume reduction of target volumes and parotid glands over the course of IMRT. Relative to the original plan, the hybrid plans demonstrated significantly higher dose to most of target volumes with greater dose inhomogeneity, higher maximum doses to the spinal cord and brainstem, and higher median doses to the parotid glands.

Conclusions

Replanning with repeat CT and MRI scans at 30 Gy is essential to keep a satisfactory dose to the target volumes and avoid overdosing the OARs.

Section snippets

Patient selection

From September 2006 to April 2008, a total of 19 patients (median age, 56 years; range, 36–74 years) with loco-regionally advanced NPC without distant metastasis treated with IMRT were prospectively enrolled in this study at the Department of Clinical Oncology, Queen Elizabeth Hospital (QEH). All patients were newly diagnosed and staged by MRI with stage III–IV according to the staging system of American Joint Committee on Cancer (AJCC 2002) [16]. Of the 19 patients, 12 were male and 7 were

Weight loss

Most patients had significant weight loss during the course of the radiotherapy. Compared with the baseline, mean weight losses at 30 and 50 Gy were −5.4% (range: +1.7% to −13.7%, p < 0.001) and −9.3% (range: 0.0% to −20.1%, p < 0.001), respectively (Supplementary Table 2).

Volume changes

Table 1 shows the volumes of different target volumes and parotid glands in OPLAN, HPLAN30 and HPLAN50. The mean initial volumes of GTV_NP and GTV_N in OPLAN were 42.7 and 13.6 cm3, respectively. With respect to the target volumes

Discussion

The volume reduction of parotid gland during a course of radiotherapy for head-and-neck cancers has been reported by many studies. X. Wang et al. documented a reduction of 20.6% and 19.8% in the left and right parotid glands of NPC patients, respectively [7] while Hansen et al. indicated a volume reduction of 21.5% and 15.6% in the left and right parotid glands, respectively for patients with head-and-neck cancers [6]. Barker et al. found that the median parotid volume loss was 28.1% [21]. In

Conclusion

Our study is unique as we have investigated the volumetric and dosimetric changes in target volumes and OARs using both CT and MRI images for NPC patients during a course of IMRT, in which most of them will suffer from significant weight loss and tumor shrinkage. With MRI, the delineation of the target volumes and many OARs would be more accurate. Recontouring on these images at 30 Gy intervals may help to identify the region for dose boosting and avoiding the critical OARs from overdose after

Conflicts of interest

None.

Acknowledgements

We wish to thank the head of the department, Dr. Stephen C. K. Law for his support, the clinical oncologists (Drs. Y. T. Fu, K. H. Au, K. C. Leung, C. K. Kwan, Alex Leung and C. C. Tong) for contouring of the target volumes and OARs; and the physicists (S. F. Liu, C. H. Cheung and W. K. Cheung) for verifying image registration. We also thank the support from the Center for Nasopharyngeal Carcinoma Research (AoE/M-06/08) under the aegis of the Area of Excellence (AoE) grant and the Seed Funding

References (33)

Cited by (65)

View all citing articles on Scopus
View full text